| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 05/09/2002 | US20020055507 Ureas and thioureas inhibit production of cytokines |
| 05/09/2002 | US20020055437 Stability of liquid formulations of various pesticides can be enhanced by utilizing quaternary ammoniuim salts |
| 05/08/2002 | EP1203770A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases |
| 05/08/2002 | EP1203766A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 05/08/2002 | EP1202988A2 Novel integrin receptor antagonists |
| 05/08/2002 | EP1202986A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 05/08/2002 | EP1202985A2 Chemokine receptor antagonists |
| 05/08/2002 | EP1202976A1 Pyrazinones, compositions containing such compounds |
| 05/08/2002 | EP1202975A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 05/08/2002 | EP1202966A1 Piperidine alcohols |
| 05/08/2002 | EP1202945A1 Methods for preparing perfluorinated [18 f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection |
| 05/08/2002 | EP1202733A1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 05/08/2002 | EP1202729A1 Phosphate transport inhibitors |
| 05/08/2002 | EP0790994B1 Heterocycle substituted propenoic acid derivatives as nmda antagonists |
| 05/08/2002 | DE10054482A1 Heteroarylacryloylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical compositions containing them |
| 05/08/2002 | CN1348447A 4,5-diaryl-3(i(2H))-furanone derivatives as cyclooxygenase-2 inhibitors |
| 05/08/2002 | CN1348441A N-substituted arylsulfonyl-lamino hydroxamic acids |
| 05/08/2002 | CN1348370A Cyclic protein tyrosine kinase inhibitors |
| 05/08/2002 | CN1347881A 法呢基蛋白转移酶抑制剂 Farnesyl protein transferase inhibitor |
| 05/08/2002 | CN1347693A Noval compound, its synthetizing process and therapeutic use |
| 05/07/2002 | US6384235 Preparation of substituted indoles |
| 05/07/2002 | US6384070 Restenosis, kidney diseases, lung diseases |
| 05/07/2002 | US6384066 Sulphonyltriazol derivatives and their use for combating micro-organisms |
| 05/07/2002 | US6384061 Hydantoin compounds and methods related thereto |
| 05/07/2002 | US6384060 2,4,6-trisbstituted pyridines with estrogenic activity and methods for the solid phase synthesis thereof |
| 05/07/2002 | US6384058 2,4,6-trisubstituted pryridines with estrogenic activity and methods for the solid phase synthesis thereof |
| 05/07/2002 | US6384057 Compounds as estrogens for treatment of deficiency |
| 05/07/2002 | US6384052 Anticoccidial compounds |
| 05/07/2002 | US6384035 Heterocycles useful in the treatment of benign prostatic hyperplasia |
| 05/07/2002 | US6384032 Inhibitors of IL-12 production |
| 05/07/2002 | US6383988 Thienysulfonylamino (thio) carbonyl compounds |
| 05/07/2002 | CA2098612C Arthropodicidal carboxanilides |
| 05/02/2002 | WO2002034746A2 Tridentate ligands and relative complexes with transition metals |
| 05/02/2002 | WO2002034745A1 Chemokine receptor binding heterocyclic compounds |
| 05/02/2002 | WO2002034740A1 Method for producing cyclic carboxylic orthoester fluorides and corresponding compounds |
| 05/02/2002 | WO2002034721A1 Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors |
| 05/02/2002 | WO2002034718A1 Amide derivatives as nmda receptor antagonists |
| 05/02/2002 | WO2002011677A3 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
| 05/02/2002 | WO2002004416A3 Lactam metalloprotease inhibitors |
| 05/02/2002 | WO2001064642A3 Benzamides and related inhibitors of factor xa |
| 05/02/2002 | WO2001024828A3 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 05/02/2002 | WO2001009121A3 2-pyrazolin-5-ones_as tyrosine kinase inhibitors |
| 05/02/2002 | US20020052514 1-(phenylmethyl)sulfonyl-2-hydroxymethyl pyrrolidine for example; use treating neurological disorders including physically damaged nerves and neurodegenerative diseases; treating alopecia and promoting hair growth |
| 05/02/2002 | US20020052512 Diaminopropionic acid derivatives |
| 05/02/2002 | US20020052510 N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres |
| 05/02/2002 | US20020052410 Administering to the animal suffering from neurological disorders an amide compound having an affinity for FKBP-type immunophilins |
| 05/02/2002 | US20020052403 Taxane formulations |
| 05/02/2002 | US20020052393 Benzanilides as potassium channel openers |
| 05/02/2002 | US20020052392 Have utility as, inter alia, hypoglycemic, and anti-obesity agents. |
| 05/02/2002 | US20020052356 Quinoline and quinazoline derivatives; prophylaxis or treatment of arthritis, cardiovascular diseases, diabetes, renal failure and particularly eating disorders and obesity. |
| 05/02/2002 | EP1201661A1 Heteroaromatic ring compounds |
| 05/02/2002 | EP1201650A2 Ionic malonitril derivatives and their uses |
| 05/02/2002 | EP1200427A2 Small molecule modulators of g protein-coupled receptor six (gpr6) |
| 05/02/2002 | EP1200426A1 Substituted thiene-3-yl-sulfonyl amino(thio)carbonyl-triazolin(thi)ones |
| 05/02/2002 | EP1200425A1 Thienyl-pyrazoles and their use for controlling pests |
| 05/02/2002 | EP1200424A1 C7 heterosubstituted acetate taxanes as antitumor agents |
| 05/02/2002 | EP1200423A1 Substituted phenyl uracils |
| 05/02/2002 | EP1200415A1 Diamino-1,2,4-triazole-carboxylic acid derivatives as gsk-3 inhibitors |
| 05/02/2002 | EP1200409A2 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 05/02/2002 | EP1200086A2 Methods for treating or preventing pain and anxiety |
| 05/02/2002 | EP1200076A1 Calcilytic compounds |
| 05/02/2002 | CA2421796A1 Chemokine receptor binding heterocyclic compounds |
| 05/02/2002 | CA2420164A1 Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors |
| 05/01/2002 | CN1347423A Catalyst contg. N-pyrrolyl substd. nitrogen donors |
| 05/01/2002 | CN1347414A Triazole compounds with dopamine-D3-receptor affinity |
| 05/01/2002 | CN1347406A Carbamic acid derivs. and their use as metabotropic glutamate receptor ligands |
| 05/01/2002 | CN1346829A Acrylate compounds and use |
| 05/01/2002 | CN1346826A Microbicidal halobenzoimidazole, composition and process for preparing same |
| 05/01/2002 | CN1083833C Sulfur-substd. azetidinone compounds useful as hypocholesterolemic agents |
| 04/30/2002 | US6380394 Anticancer agents |
| 04/30/2002 | US6380386 Insecticides, bactericides |
| 04/30/2002 | US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 04/30/2002 | US6380246 For combating pests and weeds |
| 04/30/2002 | US6380242 For diagnosis and therapy of central nervous system conditions |
| 04/30/2002 | US6380238 Indoline derivatives as 5-HT2B and or 5-HTC receptor ligands |
| 04/30/2002 | US6380235 Useful as progesterone receptor agonists and antagonists, used for contraception, in therapy of fibroids, endometriosis, breast, uterine, ovarian and prostate cancer, and post menopausal hormone replacement therapy |
| 04/30/2002 | US6380225 Microbicidal benzotriazoles |
| 04/30/2002 | US6380224 For therapy of eating disorders, obesity, bulimia nervosa, diabetes, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/reproductive disorders, depression and anxiety |
| 04/30/2002 | US6380221 Ortho-anthranilamide derivatives as anti-coagulants |
| 04/30/2002 | US6380220 Therapy of neurodegenerative diseases and neuronal injuries which are casued by ischemia, trauma or massive hemorrhages |
| 04/30/2002 | US6380218 For therapy of respiratory, allergic, and inflammatory disorders comprising asthma, chronic obstructive pulmonary disease, acute respiratory disease syndrome, pulmonary hypersensitivity, and allergic rhinitis in a mammal |
| 04/30/2002 | US6380214 Thiophene-3-carboxylic acid amide derivatives |
| 04/30/2002 | US6380210 Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors |
| 04/30/2002 | US6380201 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists |
| 04/30/2002 | US6380194 For treatment of subjects suffering from hiv infection |
| 04/30/2002 | CA2246994C Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl)¬1,4|diazepan-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 04/30/2002 | CA2241827C Novel substituted 4-(1h-benzimidazol-2-yl)¬1,4|diazepanes useful for the treatment of allergic diseases |
| 04/30/2002 | CA2088931C Phosphonooxy and carbonate derivatives of taxol |
| 04/25/2002 | WO2002032897A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| 04/25/2002 | WO2002032893A2 Piperidine compounds as anti-allergic |
| 04/25/2002 | WO2002032880A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication |
| 04/25/2002 | WO2002032879A1 Dihydropyrimidine derivatives as cysteine protease inhibitors |
| 04/25/2002 | WO2002032872A1 Nitrogenous aromatic ring compounds |
| 04/25/2002 | WO2002032864A1 Pharmaceutically active sulfanilide derivatives |
| 04/25/2002 | WO2002032863A1 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |
| 04/25/2002 | WO2002032377A2 Estrogen receptor modulators |
| 04/25/2002 | WO2002010137A3 Indazole derivatives as JNK inhibitors |
| 04/25/2002 | WO2001058891A3 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage |
| 04/25/2002 | WO2001056990A3 Pyridine derivates as potentiators of glutamate receptors |
| 04/25/2002 | WO2001002369A3 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |